Send Inquiry

Request To Call Back

Ticocin 400 mg Injection

Price 2800.0 INR/ Unit

Get a Price/Quote

MOQ : 1 Unit

Ticocin 400 mg Injection Specification

Indication
Serious infections caused by susceptible Gram-positive bacteria including MRSA

Brand Name
Ticocin

Dosage Form
Lyophilized powder for solution

Life Span
24 months from manufacture

Packaging Type
Glass vial

Pacakaging (Quantity Per Box)
1 vial per box

Origin of Medicine
India

Salt Composition
Teicoplanin (400mg)

Drug Type
Other

Ingredients
Teicoplanin (400mg)

Physical Form
Other

Function
Other

Recommended For
Adults and pediatric patients with serious Gram-positive infections

Dosage
As directed by physician

Dosage Guidelines
Intravenous or intramuscular, as prescribed

Quantity
1 vial Unit

Storage Instructions
Store below 25C, protect from light

Product Registration
WHO-GMP Certified Facility

ATC Code
J01XA02

Shelf Life
2 years from date of manufacture

Route of Administration
IV (intravenous) or IM (intramuscular) injection after reconstitution

Strength
400 mg/vial

Hazard Statement
Not for veterinary use

Manufactured By
Cipla Ltd.

Prescription Status
Rx Only (to be sold by retail on the prescription of a registered medical practitioner only)

Reconstitution
Reconstitute with provided sterile water for injection

Adverse Reactions
Possible side effects include rash, fever, or rarely nephrotoxicity or ototoxicity

Special Precautions
Monitor renal function during prolonged therapy

Contraindications
Hypersensitivity to teicoplanin or other glycopeptides

Appearance
White to off-white lyophilized powder

Therapeutic Class
Glycopeptide antibiotic

Marketed By
Cipla Ltd.- India

Ticocin 400 mg Injection Trade Information

Minimum Order Quantity
1 Unit

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Ticocin 400 mg Injection

Ticocin 400 Injection (Teicoplanin 400 mg)

Ticocin 400 Injection contains Teicoplanin 400 mg, a glycopeptide antibiotic used for the treatment of serious Gram-positive bacterial infections. It is commonly prescribed in hospital settings for infections involving the lungs, urinary tract, skin and soft tissues, bones, joints, heart, bloodstream, and other severe bacterial conditions. The injection is administered under medical supervision and is widely used when treatment with conventional antibiotics may not be suitable.

Ticocin works by inhibiting bacterial cell wall formation, leading to the destruction of susceptible bacteria. It is particularly effective against serious Gram-positive infections, including certain antibiotic-resistant organisms such as MRSA.

Ticocin 400 mg Injection, an ephemeral yet grand solution by renowned manufacturer Cipla Ltd., offers first-string support against serious Gram-positive bacterial infections like MRSA. Utilizing the glycopeptide antibiotic teicoplanin (400 mg/vial), its lyophilized powder form ensures stability and prolonged shelf-life. Designed for IV or IM administration after reconstitution, Ticocin is a WHO-GMP certified product-making it highly regarded among healthcare professionals. Benefit from markdown discounts for bulk orders with assured quality for both adults and pediatric patients. Prescription only.

Superior Therapeutic Utility and Versatile Application Media

Ticocin 400 mg Injection is tailored for prescription use in adults and children, making it versatile for acute hospital and critical care settings. Its primary advantage lies in tackling tough Gram-positive infections, especially MRSA. Available as a lyophilized powder for reconstitution, it can be administered intravenously or intramuscularly, ensuring flexibility for clinicians to adapt dosing routes as per patient needs. The formulation's potent antimicrobial activity stems from high-purity teicoplanin.

Global Export Efficiency: Markets, Ports, and Quotation Ease

Ticocin 400 mg Injection is exported extensively from India, targeting major pharmaceutical markets in Asia, Africa, Europe, and the Middle East. Packing & dispatch are managed meticulously through key FOB ports such as Mumbai and Chennai. Cipla and partners assure continuity in supply ability, accommodating substantial order volumes. Transparent quotation processes minimize expenditure for wholesalers, traders, and exporters, making procurement cost-effective and dependable.

We support procurement requirements for:

Pharmaceutical importers and distributors
Hospitals and healthcare institutions
Government tenders
NGO and humanitarian healthcare projects
Medical procurement agencies
International wholesalers

FAQ's of Ticocin 400 mg Injection:

Q: How should Ticocin 400 mg Injection be administered?

A: Ticocin 400 mg Injection must be reconstituted with the provided sterile water and then administered either via intravenous (IV) or intramuscular (IM) injection, as directed by a physician.

Q: What are the principal uses of Ticocin 400 mg Injection?

A: Ticocin is recommended for the treatment of serious infections caused by susceptible Gram-positive bacteria, including cases of MRSA, in both adults and pediatric patients.

Q: When is it necessary to monitor renal function during therapy?

A: Renal function should be monitored during prolonged Ticocin therapy to detect any potential kidney-related adverse reactions, such as nephrotoxicity.

Q: Where is Ticocin 400 mg Injection manufactured and exported from?

A: Ticocin is manufactured by Cipla Ltd. in India at a WHO-GMP certified facility and is exported globally from prominent Indian ports like Mumbai and Chennai.

Q: What are the common side effects associated with Ticocin?

A: Patients may experience rash, fever, and, in rare cases, nephrotoxicity or ototoxicity. Report any adverse effects to a healthcare professional promptly.